379 related articles for article (PubMed ID: 15650187)
1. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
3. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
4. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.
Bruss V; Hagelstein J; Gerhardt E; Galle PR
Virology; 1996 Apr; 218(2):396-9. PubMed ID: 8610467
[TBL] [Abstract][Full Text] [Related]
5. Entry of hepatitis B virus: mechanism and new therapeutic target.
Xie Y; Zhai J; Deng Q; Tiollais P; Wang Y; Zhao M
Pathol Biol (Paris); 2010 Aug; 58(4):301-7. PubMed ID: 20570056
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
7. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
8. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
9. Attachment sites and neutralising epitopes of hepatitis B virus.
Glebe D
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703
[TBL] [Abstract][Full Text] [Related]
10. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
Gripon P; Le Seyec J; Rumin S; Guguen-Guillouzo C
Virology; 1995 Nov; 213(2):292-9. PubMed ID: 7491754
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
13. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
[TBL] [Abstract][Full Text] [Related]
14. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.
Blanchet M; Sureau C
J Virol; 2007 Jun; 81(11):5841-9. PubMed ID: 17376925
[TBL] [Abstract][Full Text] [Related]
15. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries.
D'Mello F; Partidos CD; Steward MW; Howard CR
Virology; 1997 Oct; 237(2):319-26. PubMed ID: 9356343
[TBL] [Abstract][Full Text] [Related]
16. Detection of cellular receptors specific for the hepatitis B virus preS surface protein on cell lines of extrahepatic origin.
Park JH; Choi EA; Cho EW; Lee YJ; Park JM; Na SY; Kim KL
Biochem Biophys Res Commun; 2000 Oct; 277(1):246-54. PubMed ID: 11027670
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
[TBL] [Abstract][Full Text] [Related]
18. A chemical lipid modification of recombinant preS antigen to study the mechanism of HBV attachment to the host cell.
Chen B; Lian M; Xu S; Luo M; Zheng X
J Biotechnol; 2008 Oct; 137(1-4):8-13. PubMed ID: 18675858
[TBL] [Abstract][Full Text] [Related]
19. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.
Schulze A; Schieck A; Ni Y; Mier W; Urban S
J Virol; 2010 Feb; 84(4):1989-2000. PubMed ID: 20007265
[TBL] [Abstract][Full Text] [Related]
20. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
Meier A; Mehrle S; Weiss TS; Mier W; Urban S
Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
